Cells were transplanted by tail vein injection into sublethally irradiated Ly5-congenic W41 mice and PB follow-up analyses of donor contributions to the B, T and GM lineages were then performed 8, 16, and 24 weeks later as previously described HSC frequency values were calculated from limiting dilution transplant results using an on-line program (http://bioinf.wehi.edu.au/software/elda/) and a positive read-out of >1% contribution to the total PB white blood cell pool at 16 weeks. HSCs were subclassified as DSR-HSCs when they produced >1% of the PB GM cells and as LSR-HSCs when they contributed <1% of the GM cells 16 weeks after transplantation. Differentiation patterns of HSCs were subclassified as α, β, γ, and δ based on the following ratios of their contributions to the total PB GM vs (T+B)-cell pools in recipient mice assessed 16-24 weeks post-transplant (i.e., >2.0; 0.25-2.0, <0.25 with >1% contribution to the myeloid lineage, and <0.25 with <1% contribution to the myeloid lineage, respectively), as described previously .
Microarray Analysis
All arrays were robust multi-array averaged (RMA) normalized using the Bioconductor package 'xps' in R (http://www.R-project.org/) including the metacore probesets grouped by exon (Gentleman et al., 2004) . Gene annotation data was added using a combination of the NetAffx (Release 31) annotation files as well as the Bioconductor packages 'mogene10sttranscriptcluster.db' and 'Org.Mm.eg.db'. All probe sets that were not mapped to an Entrez Gene identifier were discarded. Data Above Background (DAB) scores were calculated for each probe set and those probe sets with a DAB p-value ≤0.05 in both technical replicates of at least one condition were retained. In the case of multiple probe sets mapping to the same Entrez Gene identifier, the probe set with the highest maximum absolute deviation across all chips was retained. This was done in order to maximize power in later statistical tests as it reduces multiple testing while retaining the probes with the greatest signal. Expression values were then normalized between the arrays by quantile normalization (Smyth et al., 2005) using the R package 'limma'.
Publicly available microarray data for the UG26-1B6 cell line (Gene Expression Omnibus, GSE11589) was used together with the data for the freshly isolated ESLAM cells (from above) in order to generate a list of potential secreted factors. This data (from the mouse 4302 chip) was RMA-normalized and transcripts called as present if at least one probe set had a MAS5 p-value of 0.05 or less using the R package 'affy'. Transcripts that were defined as present and that also had the gene ontology (GO) term "extracellular region" (GO:0005576)
were compared to transcripts with the gene ontology term "receptor activity" (GO:0004872) present in transcripts of fresh ESLAM cells (as defined above). "Extracellular region" transcripts from UG26 which had transcripts with "receptor activity" in fresh ESLAM cells predicted or shown to interact in either the National Institute of Aging (NIA) mouse protein-protein interaction database (Yellaboina et al., 2008) , the BioGRID database (Stark et al., 2006) or the Cytokine-cytokine receptor interaction (mmu04060) or ECM-receptor interaction (mmu04512)
entries from the Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway database (www.genome.jp/kegg/pathway.html) were retained as potential secreted factors, and their median expression and putative receptors (interacting "receptor activity" transcripts) recorded.
For pathway analysis, arrays from extracts of cells exposed to CM were grouped and compared against extracts from fresh ESLAM cells and from cells exposed to SF+IL-11 only in order to provide biological replication and minimize differences due only to differential cell cycle status. The 'romer' algorithm (a rotation based modification of the GSEA algorithm (Subramanian et al., 2005) ) was used to test for differential expression of genes in pathways from the REACTOME database (Croft et al.) (taken from the R version of the molecular signatures database, http://bioinf.wehi.edu.au/software/MSigDB/) using a mixed alternative hypothesis (i.e., the differential expression can be in both directions) with the "floor mean" test statistic and 100,000 rotations, correcting for correlation between technical replicates (Smyth et al., 2005) .
Supplemental Figure   Figure S1 . Comparison of the serial GM-, B-, and T-cell reconstituting activities of the 2 β-HSCs and their progeny produced from the first in vitro division of a single ESLAM cell.
Donor-derived contributions to the PB GM cells are shown in red, to the PB B-cells in blue, and to the PB T-cells in black. 
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Supplemental Tables   Table S1: (Gerber et al., 2002 ) NGF: nerve growth factor, AGM: aorta-gonad-metanephron, PDGF: platelet derived growth factor, EGFR: epidermal growth factor receptor, ROBO: roundabout family, BMP: bone morphogenic protein, TGF-ß: transforming growth factor-beta, VEGF: vascular endothelial growth factor. 
